Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
Among those with HIV, anemia is a strong risk factor for disease progression and death independent of CD4 count and viral load. Understanding the role of anemia in HIV treatment is critical to developing strategies to reduce morbidity and mortality. We conducted a prospective analysis among 10,259...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Journal of Tropical Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/162950 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832548343220273152 |
---|---|
author | Simbarashe Takuva Mhairi Maskew Alana T. Brennan Ian Sanne A. Patrick MacPhail Mathew P. Fox |
author_facet | Simbarashe Takuva Mhairi Maskew Alana T. Brennan Ian Sanne A. Patrick MacPhail Mathew P. Fox |
author_sort | Simbarashe Takuva |
collection | DOAJ |
description | Among those with HIV, anemia is a strong risk factor for disease progression and death independent of CD4 count and viral load. Understanding the role of anemia in HIV treatment is critical to developing strategies to reduce morbidity and mortality. We conducted a prospective analysis among 10,259 HIV-infected adults initiating first-line ART between April 2004 and August 2009 in Johannesburg, South Africa. The prevalence of anemia at ART initiation was 25.8%. Mean hemoglobin increased independent of baseline CD4. Females, lower BMI, WHO stage III/IV, lower CD4 count, and zidovudine use were associated with increased risk of developing anemia during follow-up. After initiation of ART, hemoglobin improved, regardless of regimen type and the degree of immunosuppression. Between 0 and 6 months on ART, the magnitude of hemoglobin increase was linearly related to CD4 count. However, between 6 and 24 months on ART, hemoglobin levels showed a sustained overall increase, the magnitude of which was similar regardless of baseline CD4 level. This increase in hemoglobin was seen even among patients on zidovudine containing regimens. Since low hemoglobin is an established adverse prognostic marker, prompt identification of anemia may result in improved morbidity and mortality of patients initiating ART. |
format | Article |
id | doaj-art-a6bee28ff4274d80bbed49acbdbfaaf4 |
institution | Kabale University |
issn | 1687-9686 1687-9694 |
language | English |
publishDate | 2013-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Tropical Medicine |
spelling | doaj-art-a6bee28ff4274d80bbed49acbdbfaaf42025-02-03T06:14:16ZengWileyJournal of Tropical Medicine1687-96861687-96942013-01-01201310.1155/2013/162950162950Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART RegimenSimbarashe Takuva0Mhairi Maskew1Alana T. Brennan2Ian Sanne3A. Patrick MacPhail4Mathew P. Fox5Clinical HIV Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2041, South AfricaHealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South AfricaCenter for Global Health and Development, Boston University, Boston, MA 02118, USAClinical HIV Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2041, South AfricaClinical HIV Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2041, South AfricaHealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South AfricaAmong those with HIV, anemia is a strong risk factor for disease progression and death independent of CD4 count and viral load. Understanding the role of anemia in HIV treatment is critical to developing strategies to reduce morbidity and mortality. We conducted a prospective analysis among 10,259 HIV-infected adults initiating first-line ART between April 2004 and August 2009 in Johannesburg, South Africa. The prevalence of anemia at ART initiation was 25.8%. Mean hemoglobin increased independent of baseline CD4. Females, lower BMI, WHO stage III/IV, lower CD4 count, and zidovudine use were associated with increased risk of developing anemia during follow-up. After initiation of ART, hemoglobin improved, regardless of regimen type and the degree of immunosuppression. Between 0 and 6 months on ART, the magnitude of hemoglobin increase was linearly related to CD4 count. However, between 6 and 24 months on ART, hemoglobin levels showed a sustained overall increase, the magnitude of which was similar regardless of baseline CD4 level. This increase in hemoglobin was seen even among patients on zidovudine containing regimens. Since low hemoglobin is an established adverse prognostic marker, prompt identification of anemia may result in improved morbidity and mortality of patients initiating ART.http://dx.doi.org/10.1155/2013/162950 |
spellingShingle | Simbarashe Takuva Mhairi Maskew Alana T. Brennan Ian Sanne A. Patrick MacPhail Mathew P. Fox Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen Journal of Tropical Medicine |
title | Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen |
title_full | Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen |
title_fullStr | Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen |
title_full_unstemmed | Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen |
title_short | Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen |
title_sort | anemia among hiv infected patients initiating antiretroviral therapy in south africa improvement in hemoglobin regardless of degree of immunosuppression and the initiating art regimen |
url | http://dx.doi.org/10.1155/2013/162950 |
work_keys_str_mv | AT simbarashetakuva anemiaamonghivinfectedpatientsinitiatingantiretroviraltherapyinsouthafricaimprovementinhemoglobinregardlessofdegreeofimmunosuppressionandtheinitiatingartregimen AT mhairimaskew anemiaamonghivinfectedpatientsinitiatingantiretroviraltherapyinsouthafricaimprovementinhemoglobinregardlessofdegreeofimmunosuppressionandtheinitiatingartregimen AT alanatbrennan anemiaamonghivinfectedpatientsinitiatingantiretroviraltherapyinsouthafricaimprovementinhemoglobinregardlessofdegreeofimmunosuppressionandtheinitiatingartregimen AT iansanne anemiaamonghivinfectedpatientsinitiatingantiretroviraltherapyinsouthafricaimprovementinhemoglobinregardlessofdegreeofimmunosuppressionandtheinitiatingartregimen AT apatrickmacphail anemiaamonghivinfectedpatientsinitiatingantiretroviraltherapyinsouthafricaimprovementinhemoglobinregardlessofdegreeofimmunosuppressionandtheinitiatingartregimen AT mathewpfox anemiaamonghivinfectedpatientsinitiatingantiretroviraltherapyinsouthafricaimprovementinhemoglobinregardlessofdegreeofimmunosuppressionandtheinitiatingartregimen |